SCHEMBL3364490

SCHEMBL3364490

COc1cc(O)c2c(c1)OC(c1ccccc1)C(=O)C2

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.54
CYP19A1 P11511 9/20 0.45
ALDH1A1 P00352 2/20 0.44
ADORA3 P0DMS8 1/20 0.44
MAPT P10636 1/20 0.44
ATM Q13315 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP3A4 P08684 1/20 0.44
HPGD P15428 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TAS2R31 P59538 1/20 0.44
MAOB P27338 1/20 0.43
ELAVL3 Q14576 1/20 0.43
ABCB1 P08183 1/20 0.41
AR P10275 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27974387 0.91 CYP19A1 (0.47) ABCG2CYP19A1ALDH1A1ADORA3MAPT
SCHEMBL3368235 0.91 CYP19A1 (0.53) ABCG2CYP19A1ALDH1A1ADORA3MAPT
SCHEMBL6503937 0.86 CYP19A1 (0.49) ABCG2CYP19A1ALDH1A1ADORA3MAPT
SCHEMBL2879031 0.86 ABCG2 (0.53) ABCG2CYP19A1ALDH1A1KDM4ECYP3A4
SCHEMBL1508796 0.85 MEN1 (0.49) CYP19A1ALDH1A1ADORA3MAPTTDP1
SCHEMBL14829729 0.85 CYP19A1 (0.52) ABCG2CYP19A1ALDH1A1ADORA3MAPT
SCHEMBL7200862 0.85 CYP1A1 (0.54) CYP19A1ALDH1A1ADORA3MAPTATM
SCHEMBL5084285 0.82 CYP19A1 (0.44) ABCG2CYP19A1ALDH1A1MAPTATM
SCHEMBL28552152 0.81 NPC1 (0.55) ABCG2CYP19A1MAPTABCB1
SCHEMBL5085611 0.81 CYP3A4 (0.49) CYP19A1ALDH1A1ADORA3MAPTATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893173-B1 AMINO-OXO-INDOLE-YLIDENE COMPOUNDS FOR USE IN TREATING SCALP SKIN ITCHING UNILEVER PLC (GB) 2010-10-06 EP claimed
EP-2082726-A2 Hair and/or scalp care compositions incorporating flavonoid compounds Unilever PLC (GB) 2009-07-29 EP claimed
US-20080207928-A1 Hair and/or Scalp Care Compositions Incorporating Flavonoid Compounds CONOPCO, INC. D/B/A UNILEVER 2008-08-28 US claimed
EP-1893173-A1 HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING AMINO-OXO-INDOLE-YLIDENE COMPOUNDS Unilever Plc (GB) 2008-03-05 EP claimed
WO-2006097191-A1 HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING FLAVONOID COMPOUNDS UNILEVER PLC (GB) 2006-09-21 WO claimed
CN-115721671-A Method for extracting and separating effective components of liquorice root in full-industrial-chain cooperation manner 李玉山 2023-03-03 CN disclosed
CN-107375261-B Application of the pinostrobin in prevention and treatment osteoporosis 东北林业大学 2019-11-22 CN disclosed
CN-107375261-A Application of the pinostrobin in osteoporosis is prevented and treated 东北林业大学 2017-11-24 CN disclosed
CN-103073530-B Method for preparing pinostrobin from lindera reflexa HENAN COLLEGE TRAD CHINESE MED 2014-07-23 CN disclosed
CN-103073530-A Method fro preparing pinostrobin from lindera reflexa HENAN COLLEGE TRAD CHINESE MED 2013-05-01 CN disclosed
EP-1893173-B1 AMINO-OXO-INDOLE-YLIDENE COMPOUNDS FOR USE IN TREATING SCALP SKIN ITCHING UNILEVER PLC (GB) 2010-10-06 EP disclosed
EP-2082726-A3 Hair and/or scalp care compositions incorporating flavonoid compounds Unilever PLC (GB) 2009-09-02 EP disclosed
EP-2082726-A2 Hair and/or scalp care compositions incorporating flavonoid compounds Unilever PLC (GB) 2009-07-29 EP disclosed
US-7494673-B1 Method for treatment of kidney and/or urinary system stones TORRES PHILLIP 2009-02-24 US disclosed
US-20080207928-A1 Hair and/or Scalp Care Compositions Incorporating Flavonoid Compounds CONOPCO, INC. D/B/A UNILEVER 2008-08-28 US disclosed
WO-2007115181-A9 COMPOUNDS EXHIBITING EFFLUX INHIBITOR ACTIVITY AND COMPOSITIONS AND USES THEREOF EASTMAN CHEM CO (US) 2008-04-03 WO disclosed
EP-1893173-A1 HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING AMINO-OXO-INDOLE-YLIDENE COMPOUNDS Unilever Plc (GB) 2008-03-05 EP disclosed
US-20070254859-A1 Compounds exhibiting efflux inhibitor activity and composition and uses thereof EASTMAN CHEMICAL COMPANY 2007-11-01 US disclosed
WO-2007115181-A2 COMPOUNDS EXHIBITING EFFLUX INHIBITOR ACTIVITY AND COMPOSITIONS AND USES THEREOF EASTMAN CHEMICAL COMPANY (US) 2007-10-11 WO disclosed
WO-2006097191-A1 HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING FLAVONOID COMPOUNDS UNILEVER PLC (GB) 2006-09-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254859-A1 Compounds exhibiting efflux inhibitor activity and composition and uses thereof ABCC4, NCOA4, NR4A3 ABCG2 5/4885CYP19A1 214/4885ALDH1A1 2000/4885
US-20080207928-A1 Hair and/or Scalp Care Compositions Incorporating Flavonoid Compounds POLR1C, F3, AKR1C3 ABCG2 1450/4885CYP19A1 25/4885ALDH1A1 528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.